7431-45-0 | 2-Phenylpyrimidine

Packsize	Purity	Availability	Price	Discounted Price
250mg	95%	in stock	$145.00	$102.00
1g	95%	in stock	$347.00	$243.00
5g	95%	in stock	$1,038.00	$727.00

Description

• Catalog Number: AB62947
• Chemical Name: 2-Phenylpyrimidine
• CAS Number: 7431-45-0
• Molecular Formula: C10H8N2
• Molecular Weight: 156.1839
• MDL Number: MFCD04038761
• SMILES: c1ccc(cc1)c1ncccn1

Computed Properties

• Complexity: 124
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 12
• Hydrogen Bond Acceptor Count: 2
• Rotatable Bond Count: 1
• XLogP3: 2.2

Literature

• Self-ordering of metallogrid complexes via directed hydrogen-bonding.

  Dalton transactions (Cambridge, England : 2003) 20121207

• Suppressive effects of liquid crystal compounds on the growth of U937 human leukemic monocyte lymphoma cells.

  Cancer cell international 20120101

• Identification of specific and semi-specific SIRT inhibitors through computer-aided studies.

  Aging 20110901

• Suppressive effects of liquid crystal compounds on the growth of the A549 human lung cancer cell line.

  Investigational new drugs 20110801

• Molecular dynamics simulations of the liquid-crystal phases of 2-(4-butyloxyphenyl)-5-octyloxypyrimidine and 5-(4-butyloxyphenyl)-2-octyloxypyrimidine.

  Physical review. E, Statistical, nonlinear, and soft matter physics 20100401

• Design of liquid crystals with 'de Vries-like' properties: frustration between SmA- and SmC-promoting elements.

  Journal of the American Chemical Society 20100113

• Design and Synthesis of Imidazopyrimidine Derivatives as Potent iNOS Dimerization Inhibitors.

  The open medicinal chemistry journal 20090101

• 2-Phenylpyrimidine skeleton-based electron-transport materials for extremely efficient green organic light-emitting devices.

  Chemical communications (Cambridge, England) 20081130

• Synthesis and anticancer activity of cyclopalladated complexes containing 4-hydroxy-acridine.

  Journal of inorganic biochemistry 20060901

• [Effects of liquid crystal-related compounds on human megakaryocytopoiesis and thrombopoiesis].

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20060601

• Co3(RL)2(hfac)6 ladder complex of 5-[4-(N-tert-butyl-N-aminoxyl)phenyl]pyrimidine.

  Inorganic chemistry 20060320

• Chirality transfer in ferroelectric liquid crystals.

  Accounts of chemical research 20011101

• [Selective inhibition of tyrosine kinases - a new therapeutic principle in oncology].

  Onkologie 20010901